Max Robotics — Global Service Robot Directory + US Certification

About

Anja Sander is a leading clinical researcher in surgical oncology, with a primary focus on advancing minimally invasive techniques for complex pancreatic procedures. Her work rigorously evaluates the safety, efficacy, and patient outcomes of robotic and laparoscopic approaches against traditional open surgery. Sander’s major contributions include serving as a key investigator on the landmark EUROPA trial, a randomised controlled stage 2b study comparing robotic versus open partial pancreatoduodenectomy. This high-impact work (118 citations) directly addresses the critical question of whether robotic surgery can reduce the substantial morbidity—around 40%—associated with the current gold-standard open procedure. She is also instrumental in the DISPACT-2 trial, which provides a protocol for a randomised comparison of minimally invasive versus open distal pancreatectomy, aiming to clarify the benefits of these evolving techniques. Through these methodologically rigorous trials, Sander is generating essential evidence to guide surgical decision-making and improve recovery for patients with pancreatic diseases, solidifying her reputation as a pivotal figure in evidence-based surgical innovation.